SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec gets LoA from UNICEF

26 Dec 2024 Evaluate

Panacea Biotec has received a Letter of Award (LoA) from UNICEF for supply of 115 million doses of its bivalent oral polio vaccine (bOPV) worth around $14.95 million (around Rs 127 crore) in CY2025.

The supply of bOPV to UNICEF is for its requirements in countries in Africa / Asia region as per the orders as may be received from time to time.

Panacea Biotec is a leading research based Biotechnology Company with established research, manufacturing and marketing capabilities. 

Panacea Biotec Share Price

536.70 -12.90 (-2.35%)
06-Jul-2026 15:40 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1915.55
Dr. Reddys Labs. 1368.75
Cipla 1471.25
Zydus Lifesciences 1148.90
Lupin 2490.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: